Amerise Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 18.42 million. Revenue was INR 18.58 million. Net income was INR 3.35 million compared to net loss of INR 0.098 million a year ago. Basic earnings per share from continuing operations was INR 0.05. Diluted earnings per share from continuing operations was INR 0.05.
For the six months, sales was INR 33.59 million. Revenue was INR 33.49 million compared to INR 0.002 million a year ago. Net income was INR 6.32 million compared to net loss of INR 0.19 million a year ago. Basic earnings per share from continuing operations was INR 0.1. Diluted earnings per share from continuing operations was INR 0.1.